News related to Urso (Ursodiol) and/or conditions it is approved for
AASLD: High-Dose Ursodeoxycholic Acid Fails Test in Primary Sclerosing Cholangitis
Source: MedPage Today Gastroenterology [2008.11.05]
SAN FRANCISCO (MedPage Today) -- In patients with primary sclerosing cholangitis, treatment with high-dose ursodeoxycholic acid (UDCA) may cause more harm than good, according to a study reported here.
Gene Essential To Early Brain Development Isolated By Neuroscientists
Source: Genetics News From Medical News Today [2008.11.27]
UQ neuroscientists have discovered the crucial role a specific gene plays in forming the neural tube, the earliest identifiable structure in the developing brain and an essential precursor to the entire central nervous system. While investigating neural tube closure in the clawed toad (Xenopus laevis) and in zebrafish, Associate Professor Helen Cooper at the
FDA Clears Mesoblast Limited (ASX:MSB) Bone Marrow Transplant Trial
Source: Lymphoma / Leukemia News From Medical News Today [2008.11.05]
Mesoblast Limited (ASX:MSB; USOTC: MBLTY) today announced the commencement of a Phase I/II clinical trial in the United States using the patented allogeneic, or "off-the-shelf", Mesenchymal Precursor Cells (MPCs) in up to 30 patients with haematologic malignancies undergoing bone marrow transplantation.
Primary Biliary Cirrhosis
Source: MedicineNet ursodiol Specialty [2005.09.17]
Title: Primary Biliary Cirrhosis
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 9/17/2005
|
